- Piper upgrades Forest Labs (FRX -0.2%) to Overweight from Neutral. Price target is $67.
- Morgan Stanley cuts AbbVie (ABBV -3.3%) to Equalweight from Overweight.
- Leerink downgrades Solta Medical (SLTM) to Market Perform from Outperform.
- Stifel cuts Puma Biotechnology (PBYI -0.8%) to Hold from Buy.
- Chardan starts Rockwell Medical (RMTI +3.2%) at Buy. Price target is $22.
- JMP starts Chelsea Therapeutics (CHTP +5.5%) at Market Outperform. Price target is $8.
Healthcare upgrades, downgrades, and initiations for Thursday
Dec 19 2013, 09:46 ET